Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models.

Tuberculosis is an ongoing threat to global health, especially with the emergence of multi drug-resistant (MDR) and extremely drug-resistant strains that are motivating the search for new treatment strategies. One potential strategy is immunotherapy using Innate Defence Regulator (IDR) peptides that...

Full description

Bibliographic Details
Main Authors: Bruno Rivas-Santiago, Julio E Castañeda-Delgado, Cesar E Rivas Santiago, Matt Waldbrook, Irma González-Curiel, Juan C León-Contreras, Jose Antonio Enciso-Moreno, Victor del Villar, Jazmin Mendez-Ramos, Robert E W Hancock, Rogelio Hernandez-Pando
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3605426?pdf=render